The first Emergency Use Authorization (EUA), issued Dec. 11, 2020 for the Pfizer-BioNTech COVID-19 Vaccine for individuals 16 years of age and older was based on safety and effectiveness data from a randomized, controlled, blinded ongoing clinical trial of thousands of individuals.

After the very first batch of Covid-19 Vaccines were made available to Tennessee, these precious vaccines were first administered to healthcare workers and the elderly/immunocompromised population. A large percentage of Tennessee elderly population resided in Long Term Care (LTC), Memory Care, and/or Assisted Living Facilities (ALF) and amongst those chosen to go into these facilities throughout Tennessee and administer these life saving vaccines was Pharmalife founder Dr. Marcus Jackson PharmD, MBA.